Research & Development
We have built a groundbreaking, global cancer research and development model that is designed to deliver breakthroughs for some of the world’s most challenging cancers.
Our Approach to Cancer Research
Innovation that Leads with Science and Leverages Scale
At BeOne Medicines, we are purpose-built to accelerate the development and delivery of innovative medicines to address some of the greatest unmet needs in cancer.
Our team of dedicated scientists in biology, chemistry, pharmacology, translational medicine and clinical science has a deep and nuanced understanding of cancer. They apply their diverse expertise to explore a vast selection of preclinical candidates and generate proof-of-concept data that enables us to accelerate the most promising compounds into clinical trials. This approach strengthens our ability to deliver a higher volume of potentially transformative medicines possibly as, first-or-best-in-class.
We also manage our extensive clinical research program in-house, which creates efficiencies in scale that allow for optimum decision-making and program delivery.
As we innovate with urgency, we follow a rigorous, science-forward approach to develop novel investigational medicines that:
Disrupt key drivers of cell growth and survival
Harness the body’s immune system to attack tumors
Target specific cancer biomarkers
Our Broad Clinical Program*
Innovation
See Our Pipeline
With dozens of clinical and commercial stage assets in our pipeline, we’re advancing cutting-edge science that leverages multiple technology platforms to find the best interventions for each cancer target. We’re working to deliver a precision medicine approach with the potential to improve outcomes and reduce side effects, while striving to deliver medicines sooner for people with cancer.